NEW YORK , Feb. 29, 2024 /PRNewswire/ -- The mass spectrometry market is expected to grow by USD 2.52 billion from 2022 to 2027. In addition, the momentum of the market will progress at a CAGR of 10.08% during the forecast period, according to Technavio Research. The market has been segmented by end-user (pharmaceutical and biotechnology industries, chemical and petrochemical industries, and others), product (instruments, consumables, and services ), and geography (North America, Europe, Asia, and Rest of World (ROW)). North America is estimated to contribute 42% to the growth of the global market during the forecast period. The increasing interest of some pharmaceutical companies in discovering and developing drugs is one of the main factors. In addition, there has been a strong increase in R&D activity in the Mass Spectrometry market. Read a Free PDF Sample Report
Report Coverage |
Details |
Page number |
166 |
Base year |
2022 |
Historic period |
2017-2021 |
Forecast period |
2023-2027 |
Growth momentum & CAGR |
Accelerate at a CAGR of 10.08% |
Market growth 2023-2027 |
USD 2,520.16 million |
Market structure |
Fragmented |
YoY growth 2022-2023(%) |
9.94 |
Regional analysis |
North America, Europe, Asia, and the Rest of the World (ROW) |
Performing market contribution |
North America at 42% |
Key countries |
US, Canada, Germany, UK, and China |
Company Profile:
908 Devices Inc., ABB Ltd., Agilent Technologies Inc., Bruker Corp., Endress Hauser Group Services AG, European Virtual Institute for Speciation Analysis, JEOL Ltd., Kore Technology Ltd., LECO Corp., Perkin Elmer Inc., Rigaku Corp., Shimadzu Corp., Teledyne Technologies Inc., Thermo Fisher Scientific Inc., and Waters Corp.
Agilent Technologies Inc - The company offers mass spectrometry such as triple quadrupole LC-MS, quadrupole time of flight LC-MS, and high throughput LC-MS.To gain access to more company profiles available with Technavio, buy the report!
Segmentation Analysis
The market share growth by the pharmaceutical and biotechnology industries segment will be significant during the forecast period. The development of new drugs using the inherent mass-to-charge ratio of specific molecules to reveal their structure is one of the main reasons for the growing demand for mass spectrometry in the pharmaceutical industry. View a PDF Sample Report
An increase in the use of hyphenated technology
The combination of one or more functions into a single product is known as hyphenation. It often requires two individual instruments to be built under a single casing, which can work in tandem with each other. Increased adoption of LCM instruments has been achieved as a result. In a variety of applications, the coupling of LC separations with Mass characterization was used.
- Increasing demand for portable mass spectrometers is a major trend in the market. Identify key trends, drivers, and challenges in the market. Download a sample report to gain access to this information.
Analyst Review
The Mass Spectrometry Market is experiencing significant growth attributed to various factors such as spending on pharmaceutical R&D, government regulations on drug safety, and the quality of food products. Additionally, advancements in technology have led to increased crude and shale gas production.
Governments worldwide are implementing stringent government initiatives for pollution control, which is further propelling the demand for mass spectrometry solutions in environmental testing. The pharmaceutical and biotechnology industry heavily relies on mass spectrometry for drug discovery and development processes, thereby driving R&D investments.
In the European Union, the EU Industrial R&D Investment Scoreboard showcases the region's commitment to innovation, influencing premium product pricing strategies within the mass spectrometry market. Ensuring compliance with regulatory standards is crucial for both established and emerging countries in the adoption of mass spectrometry technologies.
Within the market, various segments such as instrument, software & services, and sample preparation techniques cater to diverse end-user segments including pharma-biopharma manufacturing, research labs & academic institutes, and environmental testing labs.
Notably, techniques like LC-MS, GC-MS, and ICP-MS are pivotal in specific applications such as drug discovery, environmental testing, and clinical diagnostics. Additionally, the OMICS research segment benefits significantly from mass spectrometry technologies.
In summary, the Mass Spectrometry Market is intricately linked to numerous sectors, ranging from pharmaceutical companies to petrochemical industries, reflecting its versatile applications and broad market potential. The Mass Spectrometry Market, dominated by industry labs, thrives in the pharmaceutical sector, providing precise testing solutions. Its growth mirrors advancements in analytical technology, meeting market demands for accurate analysis and identification of compounds. Download a sample report
Related Reports:
The high throughput screening (HTS) market size is estimated to grow by USD 19.9 billion at a CAGR of 12.12% between 2023 and 2028.
The Spectrometry Market size is estimated to grow at a CAGR of 9.65% between 2022 and 2027. The market size is forecast to increase by USD 7,199.81 million.
ToC:
1 Executive Summary
2 Landscape
3 Sizing
4 Historic Size
5 Five Forces Analysis
6 Segmentations
7 Customer Landscape
8 Geographic Landscape
9 Drivers, Challenges, and Trends
10 Vendor Landscape
11 Vendor Analysis
12 Appendix
About Technavio
Technavio is a leading global technology research and advisory company. Their research and analysis focus on emerging market trends and provide actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions.
With over 500 specialized analysts, Technavio's report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio's comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.
Contacts
Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: [email protected]
Website: www.technavio.com/
SOURCE Technavio
![](https://rt.prnewswire.com/rt.gif?NewsItemId=CG49155&Transmission_Id=202402292124PR_NEWS_USPR_____CG49155&DateId=20240229)
Share this article